CNR1 and metabolic dysfunction-associated steatotic liver disease: Based on our results, it can be noted the potential usefulness of CB1 blockade in the treatment of HFD-induced NAFLD, particularly due to attenuation of hepatic oxidative/nitrosative stress parameters and improvement of liver histology.